MDPI

Hemato Template

Write in a clean editor, then format for Hemato in one click — DocuGuru applies the official MDPI template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Hemato format

Hemato is a peer-reviewed journal published by MDPI, covering Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research. Over its lifetime it has published 247 papers, which have received 771 citations.

PublisherMDPI
Reference styleNumbered (MDPI)
Numbered — [1], [2] in the text
1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Hemato 2023, 12, 45–58.

Formats any DOI in Hemato style. No sign-up.

Publishes research inLymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Acute Myeloid Leukemia Research Multiple Myeloma Research and Treatments Chronic Myeloid Leukemia Treatments
ISSN2673-6357
Citation impact (2-yr)1.17
h-index11
i10-index19
Article processing charge$1,082
Open accessYes — indexed in DOAJ
Top institutions publishing hereCentro di Riferimento Oncologico
Journal websitewww.mdpi.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Hemato per year

12
2020
55
2021
51
2022
30
2023
33
2024
45
2025

Citation impact of Hemato by publication year

27
2020
249
2021
309
2022
59
2023
63
2024
41
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Hemato

Sickle Cell Disease, a Review

Cameron K. Tebbi · 30 May 2022

Sickle cell disease and its variants constitute the most common inherited blood disorders affecting millions of individuals worldwide. Significant information regarding the nature of the genetic mutations and modifier genes that result in increased or decreased severity of the disease are available. In recent years, detailed data regarding molecular genetics, pathophysiology, mechanisms for the development…

Burkitt Lymphoma Incidence in Five Continents

Sam M. Mbulaiteye, Susan S. Devesa · 13 Jul 2022

Burkitt lymphoma (BL) is a rare non-Hodgkin lymphoma first described in 1958 by Denis Burkitt in African children. BL occurs as three types, endemic, which occurs in Africa and is causally attributed to Epstein-Barr virus and P. falciparum infections; sporadic, which occurs in temperate areas, but the cause is obscure; and immunodeficiency-type, which is associated…

Barriers and Facilitators of Use of Hydroxyurea among Children with Sickle Cell Disease: Experiences of Stakeholders in Tanzania

Manase Kilonzi, Hamu J. Mlyuka, Fatuma Felix Felician et al. · 28 Nov 2021

Factors contributing to low use of HU among SCD patients exist in high-income countries. The latter leaves a drift of literature on factors for low utilization of HU in developing countries. This study aimed to explore the factors influencing the use of HU in the management of SCD in Tanzania. A qualitative study was employed…

Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis

Gareth J. Morgan, Joel N. Buxbaum, Jeffery W. Kelly · 5 Oct 2021

Non-native immunoglobulin light chain conformations, including aggregates, appear to cause light chain amyloidosis pathology. Despite significant progress in pharmacological eradication of the neoplastic plasma cells that secrete these light chains, in many patients impaired organ function remains. The impairment is apparently due to a subset of resistant plasma cells that continue to secrete misfolding-prone light…

Integrative Statistics, Machine Learning and Artificial Intelligence Neural Network Analysis Correlated CSF1R with the Prognosis of Diffuse Large B-Cell Lymphoma

Joaquim Carreras, Yara Yukie Kikuti, Masashi Miyaoka et al. · 10 Apr 2021

Tumor-associated macrophages (TAMs) of the immune microenvironment play an important role in the Diffuse Large B-cell Lymphoma (DLBCL) pathogenesis. This research aimed to characterize the expression of macrophage colony-stimulating factor 1 receptor (CSF1R) at the gene and protein level in correlation with survival. First, the immunohistochemical expression of CSF1R was analyzed in a series of…

Hemato template — frequently asked questions

How do I write a paper in the Hemato format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Hemato template. When you export, DocuGuru compiles the paper into the official MDPI format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Hemato use?
Hemato uses Numbered (MDPI) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith, A.; Jones, B.; Lee, C. A Representative Article Title. Hemato 2023, 12, 45–58.
Do I need to know LaTeX to submit to Hemato?
No. DocuGuru generates the mdpi LaTeX class and compiles the PDF for you in the background, so you get a MDPI-ready Hemato document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Hemato template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Hemato format with correct headings, figures, tables, and numbered citations.
What is Hemato?
Hemato - MDPI Journal. It is a multidisciplinary journal, published by MDPI.
Can I export a submission-ready Hemato PDF?
Yes — DocuGuru produces a PDF built with the official Hemato template (the mdpi class) that is ready to submit to MDPI, together with the matching LaTeX source files.
How much does the Hemato template cost?
You can start writing in the Hemato template for free. Exporting the final submission-ready Hemato PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Hemato template